Gene delivery platforms

Biotechnology and Bioprocess Engineering

Volumn 18, Issue 4, 2013, Pages 637-647

  Kim, Jong Myung ^a,b   Shin, Eunkyoung ^b   Ryou, Sang Mi ^b   Yeom, Ji Hyun ^b   Lee, Kangseok ^b  

^a Life and Environment Research Center of JM ENB   (South Korea)

^b Chung Ang University   (South Korea)

Author keywords

GDS; gene delivery system; nanoparticle; non viral GDS; viral GDS

Indexed keywords

GDS; GENE DELIVERY; GENE DELIVERY AGENTS; GENE DELIVERY SYSTEMS; LIVING SYSTEMS; NONVIRAL; THERAPEUTIC USE; VIRAL GDS;

NANOPARTICLES; NUCLEIC ACIDS;

GENE TRANSFER;

ADENOVIRUS VECTOR; CARBON NANOTUBE; CHITOSAN; DENDRIMER; GOLD NANOPARTICLE; HERPESVIRUS VECTOR; LENTIVIRUS VECTOR; LIPID; NANOPARTICLE; PARVOVIRUS VECTOR; POLYETHYLENEIMINE; POLYLYSINE; RETROVIRUS VECTOR; SILICA NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; COMPLEX FORMATION; DRUG CONJUGATION; DRUG RELEASE; ELECTROPORATION; GENE TRANSFER; HUMAN; LONG TERMINAL REPEAT; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEAR LOCALIZATION SIGNAL; PROTEIN BINDING; REVIEW; VIRAL GENE DELIVERY SYSTEM; VIRUS CELL INTERACTION;

EID: 84882715270     PISSN: 12268372     EISSN: 19763816     Source Type: Journal    
DOI: 10.1007/s12257-012-0546-8     Document Type: Review

References (85)

1. Gardlik, R., R. Palffy, J. Hodosy, J. Lukacs, J. Turna, and P. Celec (2005) Vectors and delivery systems in gene therapy. Med. Sci. Monit. 11: 110-121.
2. Lundstrom, K. and T. Boulikas (2003) Viral and non-viral vectors in gene therapy: Technology development and clinical trials. Technol. Cancer Res. Treat. 2: 471-486.
3. Mukherjee, S., R. N. Ghosh, and F. R. Maxfield (1997) Endocytosis. Physiol. Rev. 77: 759-803.
4. Boussif, O., F. Lezoualc'h, M. A. Zanta, M. D. Mergny, D. Scherman, B. Demeneix, and J. P. Behr (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc. Natl. Acad. Sci. USA. 92: 7297-7301.
5. Friend, D. S., D. Papahadjopoulos, and R. J. Debs (1996) Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes. Biochim. Biophys. Acta 1278: 41-50.
6. El Ouahabi, A., M. Thiry, V. Pector, R. Fuks, J. M. Ruysschaert, and M. Vandenbranden (1997) The role of endosome destabilizing activity in the gene transfer process mediated by cationic lipids. FEBS Lett. 414: 187-192.
7. Prasad, T. K. and N. M. Rao (2005) The role of plasmid constructs containing the SV40 DNA nuclear-targeting sequence in cationic lipid-mediated DNA delivery. Cell Mol. Biol. Lett. 10: 203-215.
8. Rosenberg, S. A., P. Aebersold, K. Cornetta, A. Kasid, R. A. Morgan, R. Moen, E. M. Karson, M. T. Lotze, J. C. Yang, and S. L. Topalian (1990) Gene transfer into humans - immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N. Engl. J. Med. 323: 570-578.
9. Yu, S. F., T. von Ruden, P. W. Kantoff, C. Garber, M. Seiberg, U. Ruther, W. F. Anderson, E. F. Wagner, and E. Gilboa (1986) Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc. Natl. Acad. Sci. USA. 83: 3194-3198.
10. Hacein-Bey-Abina, S., F. Le Deist, F. Carlier, C. Bouneaud, C. Hue, J. P. De Villartay, A. J. Thrasher, N. Wulffraat, R. Sorensen, S. Dupuis-Girod, A. Fischer, E. G. Davies, W. Kuis, L. Leiva, and M. Cavazzana-Calvo (2002) Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl. J. Med. 346: 1185-1193.
11. Rainov, N. G. and H. Ren (2003) Clinical trials with retrovirus mediated gene therapy - what have we learned? J. Neurooncol. 65: 227-236.
12. Weinberg, J. B., T. J. Matthews, B. R. Cullen, and M. H. Malim (1991) Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes. J. Exp. Med. 174: 1477-1482.
13. Follenzi, A., G. Sabatino, A. Lombardo, C. Boccaccio, and L. Naldini (2002) Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. Hum. Gene Ther. 13: 243-260.
14. Bett, A. J., W. Haddara, L. Prevec, and F. L. Graham (1994) An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA. 91: 8802-8806.
15. Yang, Y., K. U. Jooss, Q. Su, H. C. Ertl, and J. M. Wilson (1996) Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther. 3: 137-144.
16. Chia, M. C., W. Shi, J. H. Li, O. Sanchez, C. A. Strathdee, D. Huang, P. Busson, H. J. Klamut, and F. F. Liu (2004) A conditionally replicating adenovirus for nasopharyngeal carcinoma gene therapy. Mol. Ther. 9: 804-817.
17. Murphy, J. E., S. Zhou, K. Giese, L. T. Williams, J. A. Escobedo, and V. J. Dwarki (1997) Long-term correction of obesity and diabetes in genetically obese mice by a single intramuscular injection of recombinant adeno-associated virus encoding mouse leptin. Proc. Natl. Acad. Sci. USA. 94: 13921-13926.
18. Wright, J. F., G. Qu, C. Tang, and J. M. Sommer (2003) Recombinant adeno-associated virus: formulation challenges and strategies for a gene therapy vector. Curr. Opin. Drug. Discov. Devel. 6: 174-178.
19. Wendtner, C. M., D. M. Kofler, H. D. Theiss, C. Kurzeder, R. Buhmann, C. Schweighofer, L. Perabo, S. Danhauser-Riedl, J. Baumert, W. Hiddemann, M. Hallek, and H. Buning (2002) Efficient gene transfer of CD40 ligand into primary B-CLL cells using recombinant adeno-associated virus (rAAV) vectors. Blood 100: 1655-1661.
20. Manservigi, R., R. Argnani, and P. Marconi (2010) HSV Recombinant Vectors for Gene Therapy. Open Virol. J. 4: 123-156.
21. Carpenter, D. E. and J. G. Stevens (1996) Long-term expression of a foreign gene from a unique position in the latent herpes simplex virus genome. Hum. Gene Ther. 7: 1447-1454.
22. Yang, N. S., J. Burkholder, B. Roberts, B. Martinell, and D. McCabe (1990) In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc. Natl. Acad. Sci. USA. 87: 9568-9572.
23. O'Brien, J. and S. C. Lummis (2002) An improved method of preparing microcarriers for biolistic transfection. Brain Res. Brain Res. Protoc. 10: 12-15.
24. Heller, L. C., K. Ugen, and R. Heller (2005) Electroporation for targeted gene transfer. Expert. Opin. Drug Deliv. 2: 255-268.
25. Gao, X., K. S. Kim, and D. Liu (2007) Nonviral gene delivery: What we know and what is next. Aaps. J. 9: 92-104.
26. Meir, Y. J. and S. C. Wu (2011) Transposon-based vector systems for gene therapy clinical trials: challenges and considerations. Chang. Gung. Med. J. 34: 565-579.
27. Blau, S., T. T. Jubeh, S. M. Haupt, and A. Rubinstein (2000) Drug targeting by surface cationization. Crit. Rev. Ther. Drug Carrier Syst. 17: 425-465.
28. Frankel, A. D. and C. O. Pabo (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell. 55: 1189-1193.
29. Pierschbacher, M. D. and E. Ruoslahti (1984) Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309: 30-33.
30. Hart, S. L., R. P. Harbottle, R. Cooper, A. Miller, R. Williamson, and C. Coutelle (1995) Gene delivery and expression mediated by an integrin-binding peptide. Gene Ther. 2: 552-554.
31. Kircheis, R., A. Kichler, G. Wallner, M. Kursa, M. Ogris, T. Felzmann, M. Buchberger, and E. Wagner (1997) Coupling of cellbinding ligands to polyethylenimine for targeted gene delivery. Gene Ther. 4: 409-418.
32. Hashida, M., S. Takemura, M. Nishikawa, and Y. Takakura (1998) Targeted delivery of plasmid DNA complexed with galactosylated poly(L-lysine). J. Control. Rel. 53: 301-310.
33. Blessing, T., M. Kursa, R. Holzhauser, R. Kircheis, and E. Wagner (2001) Different strategies for formation of pegylated EGFconjugated PEI/DNA complexes for targeted gene delivery. Bioconjug. Chem. 12: 529-537.
34. Fischer, D., T. Bieber, Y. Li, H. P. Elsasser, and T. Kissel (1999) A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: Effect of molecular weight on transfection efficiency and cytotoxicity. Pharm. Res. 16: 1273-1279.
35. Fischer, D., Y. Li, B. Ahlemeyer, J. Krieglstein, and T. Kissel (2003) In vitro cytotoxicity testing of polycations: Influence of polymer structure on cell viability and hemolysis. Biomat. 24: 1121-1131.
36. Yao, H., S. S. Ng, W. O. Tucker, Y. K. Tsang, K. Man, X. M. Wang, B. K. Chow, H. F. Kung, G. P. Tang, and M. C. Lin (2009) The gene transfection efficiency of a folate-PEI600-cyclodextrin nanopolymer. Biomat. 30: 5793-5803.
37. Lu, Z. X., L. T. Liu, and X. R. Qi (2011) Development of small interfering RNA delivery system using PEI-PEG-APRPG polymer for antiangiogenic vascular endothelial growth factor tumortargeted therapy. Int. J. Nanomed. 6: 1661-1673.
38. Guo, Q. F., T. T. Liu, X. Yan, X. H. Wang, S. Shi, F. Luo, and Z. Y. Qian (2011) Synthesis and properties of a novel biodegradable poly(ester amine) copolymer based on poly(L-lactide) and low molecular weight polyethylenimine for gene delivery. Int. J. Nanomed. 6: 1641-1649.
39. 2+. Anal. Chem. 83: 3126-3132.
40. Midoux, P. and M. Monsigny (1999) Efficient gene transfer by histidylated polylysine/pDNA complexes. Bioconjug. Chem. 10: 406-411.
41. Huh, M. S., S. Y. Lee, S. Park, S. Lee, H. Chung, Y. Choi, Y. K. Oh, J. H. Park, S. Y. Jeong, K. Choi, K. Kim, and I. C. Kwon (2010) Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice. J. Control. Rel. 144: 134-143.
42. Ji, A. M., D. Su, O. Che, W. S. Li, L. Sun, Z. Y. Zhang, B. Yang, and F. Xu (2009) Functional gene silencing mediated by chitosan/ siRNA nanocomplexes. Nanotechnol. 20: 405103.
43. Talaei, F., E. Azizi, R. Dinarvand, and F. Atyabi (2011) Thiolated chitosan nanoparticles as a delivery system for antisense therapy: Evaluation against EGFR in T47D breast cancer cells. Int. J. Nanomed. 6: 1963-1975.
44. Ofek, P., W. Fischer, M. Calderon, R. Haag, and R. Satchi-Fainaro (2010) In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers. FASEB J. 24: 3122-3134.
45. Li, J., Y. C. Chen, Y. C. Tseng, S. Mozumdar, and L. Huang (2010) Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery. J. Control. Rel. 142: 416-421.
46. Barichello, J. M., T. Ishida, and H. Kiwada (2010) Complexation of siRNA and pDNA with cationic liposomes: The important aspects in lipoplex preparation. Methods Mol. Biol. 605: 461-472.
47. Semple, S. C., A. Akinc, J. X. Chen, A. P. Sandhu, B. L. Mui, C. K. Cho, D. W. Y. Sah, D. Stebbing, E. J. Crosley, E. Yaworski, I. M. Hafez, J. R. Dorkin, J. Qin, K. Lam, K. G. Rajeev, K. F. Wong, L. B. Jeffs, L. Nechev, M. L. Eisenhardt, M. Jayaraman, M. Kazem, M. A. Maier, M. Srinivasulu, M. J. Weinstein, Q. M. Chen, R. Alvarez, S. A. Barros, S. De, S. K. Klimuk, T. Borland, V. Kosovrasti, W. L. Cantley, Y. K. Tam, M. Manoharan, M. A. Ciufolini, M. A. Tracy, A. de Fougerolles, I. MacLachlan, P. R. Cullis, T. D. Madden, and M. J. Hope (2010) Rational design of cationic lipids for siRNA delivery. Nat. Biotechnol. 28: 172-118.
48. Spagnou, S., A. D. Miller, and M. Keller (2004) Lipidic carriers of siRNA: Differences in the formulation, cellular uptake, and delivery with plasmid DNA. Biochem. 43: 13348-13356.
49. Peer, D., E. J. Park, Y. Morishita, C. V. Carman, and M. Shimaoka (2008) Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target. Sci. 319: 627-630.
50. Guissouma, H., M. S. Froidevaux, Z. Hassani, and B. A. Demeneix (2006) In vivo siRNA delivery to the mouse hypothalamus confirms distinct roles of TR beta isoforms in regulating TRH transcription. Neurosci. Lett. 406: 240-243.
51. Taetz, S., A. Bochot, C. Surace, S. Arpicco, J. M. Renoir, U. F. Schaefer, V. Marsaud, S. Kerdine-Roemer, C. M. Lehr, and E. Fattal (2009) Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells. Oligonucleotides. 19: 103-116.
52. Zimmermann, T. S., A. C. Lee, A. Akinc, B. Bramlage, D. Bumcrot, M. N. Fedoruk, J. Harborth, J. A. Heyes, L. B. Jeffs, M. John, A. D. Judge, K. Lam, K. McClintock, L. V. Nechev, L. R. Palmer, T. Racie, I. Rohl, S. Seiffert, S. Shanmugam, V. Sood, J. Soutschek, I. Toudjarska, A. J. Wheat, E. Yaworski, W. Zedalis, V. Koteliansky, M. Manoharan, H. P. Vornlocher, and I. MacLachlan (2006) RNAi-mediated gene silencing in nonhuman primates. Nature 441: 111-114.
53. Namiki, Y., T. Namiki, H. Yoshida, Y. Ishii, A. Tsubota, S. Koido, K. Nariai, M. Mitsunaga, S. Yanagisawa, H. Kashiwagi, Y. Mabashi, Y. Yumoto, S. Hoshina, K. Fujise, and N. Tada (2009) A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery. Nat. Nanotechnol. 4: 598-606.
54. Filion, M. C. and N. C. Phillips (1998) Major limitations in the use of cationic liposomes for DNA delivery. Int. J. Pharm. 162: 159-170.
55. Belting, M. and P. Petersson (1999) Protective role for proteoglycans against cationic lipid cytotoxicity allowing optimal transfection efficiency in vitro. Biochem J. 342: 281-286.
56. Loisel, S., C. Le Gall, L. Doucet, C. Ferec, and V. Floch (2001) Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes. Hum. Gene Ther. 12: 685-696.
57. Li, S., S. P. Wu, M. Whitmore, E. J. Loeffert, L. Wang, S. C. Watkins, B. R. Pitt, and L. Huang (1999) Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors. Am. J. Physiol. 276: 796-804.
58. Dokka, S., D. Toledo, X. G. Shi, V. Castranova, and Y. Rojanasakul (2000) Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes. Pharmaceut. Res. 17: 521-525.
59. Dobson, J. (2006) Gene therapy progress and prospects: Magnetic nanoparticle-based gene delivery. Gene Ther. 13: 283-287.
60. Scherer, F., M. Anton, U. Schillinger, J. Henke, C. Bergemann, A. Kruger, B. Gansbacher, and C. Plank (2002) Magnetofection: Enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther. 9: 102-109.
61. Chen, G. H., W. J. Chen, Z. Wu, R. X. Yuan, H. Li, J. M. Gao, and X. T. Shuai (2009) MRI-visible polymeric vector bearing CD3 single chain antibody for gene delivery to T cells for immunosuppression. Biomat. 30: 1962-1970.
62. Iijima, S. (1991) Helical microtubules of graphitic carbon. Nature 354: 56-58.
63. Podesta, J. E., K. T. Al-Jamal, M. A. Herrero, B. Tian, H. Ali- Boucetta, V. Hegde, A. Bianco, M. Prato, and K. Kostarelos (2009) Antitumor activity and prolonged survival by carbon-nanotube-mediated therapeutic siRNA silencing in a human lung xenograft model. Small. 5: 1176-1185.
64. Bottini, M., N. Rosato, and N. Bottini (2011) PEG-modified carbon nanotubes in biomedicine: Current status and challenges ahead. Biomacromol. 12: 3381-3393.
65. Radu, D. R., C. Y. Lai, K. Jeftinija, E. W. Rowe, S. Jeftinija, and V. S. Lin (2004) A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. J. Am. Chem. Soc. 126: 13216-13217.
66. Yang, J., J. Lee, J. Kang, K. Lee, J. S. Suh, H. G. Yoon, Y. M. Huh, and S. Haam (2008) Hollow silica nanocontainers as drug delivery vehicles. Langmuir. 24: 3417-3421.
67. Zhu, S. G., J. J. Xiang, X. L. Li, S. R. Shen, H. B. Lu, J. Zhou, W. Xiong, B. C. Zhang, X. M. Nie, M. Zhou, K. Tang, and G. Y. Li (2004) Poly(L-lysine)-modified silica nanoparticles for the delivery of antisense oligonucleotides. Biotechnol. Appl. Biochem. 39: 179-187.
68. Xia, T., M. Kovochich, M. Liong, H. Meng, S. Kabehie, S. George, J. I. Zink, and A. E. Nel (2009) Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano. 3: 3273-3286.
69. Lee, H., D. Sung, M. Veerapandian, K. Yun, and S. W. Seo (2011) PEGylated polyethyleneimine grafted silica nanoparticles: Enhanced cellular uptake and efficient siRNA delivery. Anal. Bioanal. Chem. 400: 535-545.
70. Schmid, G. (1992) Large clusters and colloids - metals in the embryonic state. Chem. Rev. 92: 1709-1727.
71. Brust, M., M. Walker, D. Bethell, D. J. Schiffrin, and R. Whyman (1994) Synthesis of Thiol-derivatized gold nanoparticles in a 2-phase liquid-liquid system. J. Chem. Soc. Chem. Comm. 801-802.
72. Connor, E. E., J. Mwamuka, A. Gole, C. J. Murphy, and M. D. Wyatt (2005) Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small. 1: 325-327.
73. Goodman, C. M., C. D. McCusker, T. Yilmaz, and V. M. Rotello (2004) Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug. Chem. 15: 897-900.
74. Pan, Y., A. Leifert, D. Ruau, S. Neuss, J. Bornemann, G. Schmid, W. Brandau, U. Simon, and W. Jahnen-Dechent (2009) Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small. 5: 2067-2076.
75. Kumar, S., J. Aaron, and K. Sokolov (2008) Directional conjugation of antibodies to nanoparticles for synthesis of multiplexed optical contrast agents with both delivery and targeting moieties. Nat. Protoc. 3: 314-320.
76. Mirkin, C. A., R. L. Letsinger, R. C. Mucic, and J. J. Storhoff (1996) A DNA-based method for rationally assembling nanoparticles into macroscopic materials. Nature 382: 607-609.
77. Rosi, N. L., D. A. Giljohann, C. S. Thaxton, A. K. Lytton-Jean, M. S. Han, and C. A. Mirkin (2006) Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Sci. 312: 1027-1030.
78. Sandhu, K. K., C. M. McIntosh, J. M. Simard, S. W. Smith, and V. M. Rotello (2002) Gold nanoparticle-mediated transfection of mammalian cells. Bioconjug. Chem. 13: 3-6.
79. Guo, S., Y. Huang, Q. Jiang, Y. Sun, L. Deng, Z. Liang, Q. Du, J. Xing, Y. Zhao, P. C. Wang, A. Dong, and X. J. Liang (2010) Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte. ACS Nano. 4: 5505-5511.
80. Kong, W. H., K. H. Bae, S. D. Jo, J. S. Kim, and T. G. Park (2012) Cationic lipid-coated gold nanoparticles as efficient and non-cytotoxic intracellular siRNA delivery vehicles. Pharmaceut. Res. 29: 362-374.
81. Kim, J. H., H. H. Jang, S. M. Ryou, S. Kim, J. Bae, K. Lee, and M. S. Han (2010) A functionalized gold nanoparticles-assisted universal carrier for antisense DNA. Chem. Commun. (Camb). 46: 4151-4153.
82. Ryou, S. M., S. Kim, H. H. Jang, J. H. Kim, J. H. Yeom, M. S. Eom, J. Bae, M. S. Han, and K. Lee (2010) Delivery of shRNA using gold nanoparticle-DNA oligonucleotide conjugates as a universal carrier. Biochem. Biophys. Res. Commun. 398: 542-546.
83. Ryou, S. M., M. Park, J. M. Kim, C. O. Jeon, C. H. Yun, S. H. Han, S. W. Kim, Y. Lee, S. Kim, M. S. Han, J. Bae, and K. Lee (2011) Inhibition of xenograft tumor growth in mice by gold nanoparticle-assisted delivery of short hairpin RNAs against Mcl-1L. J. Biotechnol. 156: 89-94.
84. Giljohann, D. A., D. S. Seferos, P. C. Patel, J. E. Millstone, N. L. Rosi, and C. A. Mirkin (2007) Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles. Nano Lett. 7: 3818-3821.
85. Kim, Y. J., S. M. Ryou, S. Kim, J. H. Yeom, M. S. Han, K. Lee, and M. J. Seong (2012) Enhanced protein-mediated binding between oligonucleotide-gold nanoparticle composites and cell surfaces: Co-transport of proteins and composites. J Mater. Chem. 22: 25036-25041.